RECRUITING

Multi-disciplinary Care for Brain Metastases

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.

Official Title

Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases

Quick Facts

Study Start:2023-11-16

Study Completion:2025-11-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06280300

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Patients of all genders must be at least 18 years of age. * Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms. * Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact). * Patients must be able to complete questionnaires in English. * Patients must have the ability to provide informed consent.	* Patients who are \< 18 years of age are not eligible. * Patients who are Pregnant are not eligible.

Inclusion Criteria

Exclusion Criteria

* Patients of all genders must be at least 18 years of age.
* Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
* Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
* Patients must be able to complete questionnaires in English.
* Patients must have the ability to provide informed consent.

* Patients who are \< 18 years of age are not eligible.
* Patients who are Pregnant are not eligible.

Contacts and Locations

Study Contact

Alissa A Thomas, MD

CONTACT

802-847-8400

athoma21@med.uvm.edu

Study Locations (Sites)

University of Vermont Medical Center

Burlington, Vermont, 05401

United States

Collaborators and Investigators

Sponsor: University of Vermont Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-16

Study Completion Date2025-11-01

Study Record Updates

Study Start Date2023-11-16

Study Completion Date2025-11-01

Terms related to this study

Additional Relevant MeSH Terms

Brain Metastases, Adult